Novavax, Inc. (NASDAQ:NVAX)
CAPS Rating:
A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.
A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.
Recs
take recent gains off the table